At DAWN Alzheimer’s Research, we’re not just studying a disease; we’re building a movement. By joining our study, you become a crucial part of a groundbreaking journey to unravel the complexities of Alzheimer’s disease. Your participation could be the key to unlocking new insights and paving the way for innovative treatments.
Make a Difference Today
Your participation in the DAWN study is more than just a contribution to research; it’s a step towards a world where Alzheimer’s is a challenge of the past. Join us in this vital mission – together, we can make a lasting impact.
You do not need to have health insurance to participate in this study. We will not send a bill to either you or your insurance if you have it. Participation in these studies will not affect your medical coverage or any other benefit received by the government.
By participating in research studies, African Americans and Hispanic/Latinos can help scientists understand more about the genetic causes of Alzheimer’s disease and ensure that when new treatments are developed they will be able to benefit from these groundbreaking discoveries.
There is NO cost to participate.
Alzheimer’s disease is the most common form of dementia (severe memory loss) in the elderly. Alzheimer’s disease and other dementias affects approximately fifty-five million people worldwide with 6.7 million in the United States. Alzheimer’s disease affects parts of the brain that control memory, thinking, language and judgement.
There is currently no cure for Alzheimer’s disease; however, there is medicine available that can temporarily reduce the symptoms. Support is also available to help someone with the condition, and their family, cope with everyday life.
Doctors diagnose Alzheimer’s and other types of dementia based on a thorough medical history, physical examination and laboratory tests. The evaluation also includes an assessment of the characteristic changes in thinking, day-to-day function, and behavior associated with each type of change. Doctors can determine that a person has dementia with a high level of certainty. To be absolutely sure of the diagnosis, doctors need to look at the brain after someone has died.
DAWN Alzheimer’s Research focuses on understanding the genetic causes of Alzheimer’s disease in individuals of African ancestry (both in the US and Africa) and individuals of Hispanic/Latino origin to identify new preventions and treatments.
African American, African and Hispanic/Latino individuals have not been represented in research on Alzheimer’s disease. DAWN seeks to change that and include African American, African, and Hispanic/Latino individuals in ongoing research. This will help ensure that new treatments for Alzheimer’s disease will benefit individuals from all backgrounds.